PITTSBURGH, PA--(Marketwired - Mar 19, 2014) - Medical diagnostic device manufacturer Neuro Kinetics, Inc., (NKI) (www.neuro-kinetics.com) will showcase the precision of its diagnostic devices and ...

PITTSBURGH, PA--(Marketwire - Oct 17, 2012) - Continuing its push to develop new clinical testing protocols for earlier and more accurate disease diagnosis, medical device manufacturer Neuro Kinetics, ...

GENT, Belgium & MALVERN, Pa. & TOKYO, June 04, 2025--(BUSINESS WIRE)--H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G sTREM2 ...

Just the other day, a middle aged fellow approached me and said, "I think I might have Asperger's. Do you think there is any point to my getting tested, or am I too old?" I looked at him as I pondered ...

* Based on testing of 2,500 TV commercials worldwide, Neuro Insight's target for 'Peak Memory' encoding for a TV ad is an indexed 0.70. The common range for most brain activity is 0.30 to 0.70. * ...

* Based on testing of 2,500 TV commercials worldwide, Neuro Insight's target for 'Peak Memory' encoding for a TV ad is an indexed 0.70. The common range for most brain activity is 0.30 to 0.70. * ...

PITTSBURGH, PA--(Marketwired - Mar 19, 2014) - Medical diagnostic device manufacturer Neuro Kinetics, Inc., (NKI) (www.neuro-kinetics.com) will showcase the precision of its diagnostic devices and ...

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only For media: Public Relations Section, Public ...

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G sTREM2 assay for the fully automated LUMIPULSE® G immunoassay analyzers. This ...